Biggest change to treatment of RA since the introduction of biologics in the early 2000s
11 June 2021
This article was original published on 11th June 2021 on www.hah.co.uk Sciensus is the new name for Healthcare at Home.
We are delighted to share the news, from one of our main charity partners, The National Rheumatoid Arthritis Society NRAS, that the National Institute for Health and Care Excellence (NICE) has issued draft guidance approving certain anti-TNF therapies to be prescribed for people with so-called ‘moderate’ rheumatoid arthritis. The outcome of NRAS’ campaigning over the last four years is a huge step forward in providing equity of access to effective treatments for the many thousands of people who live with disease. It will also provide patients with the opportunity to get treated quicker in their disease progression. For more information, please visit the NRAS website.